Security key
09061G101
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 181,117,177
- Total 13F value
- $12,795,609,480
- Share change
- -1,584,010
- Put/Call ratio
- 74%
- SEC-reported price per share
- $70.69
- Number of holders
- 576
- Value change
- -$83,582,224
- Number of buys
- 334
- Number of sells
- 221
- Shares outstanding
- 192,632,743
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q1 2025
Institutions
576
Top holders
10
BMRN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
BIOMARIN PHARMACEUTICAL INC SEC filings
BIOMARIN PHARMACEUTICAL INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09061G101
Recent filing periods:
Ownership snapshot
Top reported holders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital Research Global I...
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
13D/G
Lead comparable stake: 4.8%
13D/G row: Capital Research Global Investors
Showing 1-6 of 15 holder rows.
Quick read
Capital Research Global Investors leads the comparable SEC ownership view at 4.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Capital Research Global Investors
4.8%
BlackRock, Inc.
12%
VANGUARD GROUP INC
10%
PRIMECAP MANAGEMENT CO/CA/
9.4%
DODGE & COX
7.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
13D/G
Company
|
4.8%
from 13D/G
|
$853,944,202
12,991,772 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
12%
|
$1,545,517,113
23,513,116 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
10%
|
$1,273,333,721
19,372,185 shares
|
— | 31 Dec 2024 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
9.4%
|
$1,195,574,211
18,189,171 shares
|
— | 31 Dec 2024 |
| DODGE & COX |
13F
Company
|
7.7%
|
$969,270,027
14,746,235 shares
|
— | 31 Dec 2024 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
5.5%
|
$690,858,452
10,510,550 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
576
Shares
181,117,177
Rows available
576
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
536
Q1 2025 holders
576
Holder diff
40
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend